[Prognosis and therapy of multiple myeloma].
Criteria for the diagnosis of multiple myeloma and differential diagnostic considerations are presented. The indications for treatment are discussed. Combination of melphalan or cyclophosphamide with prednisone may be considered standard therapy today. This produces objective tumor regression in 50-70% of patients. The parameters for determining remission and their significance with regard to survival and tumor cell mass are discussed. The importance of supportive measures is stressed. Persistent problems and potential for improving present therapy are discussed.
D001803:Blood Transfusion; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008558:Melphalan / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000628:therapy*; D009983:Orthopedic Equipment; D010146:Pain / Q000532:radiotherapy; D010956:Plasmapheresis; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012075:Remission, Spontaneous
D003520:Cyclophosphamide; D008558:Melphalan; D011241:Prednisone
Prognose und Therapie des multiplen Myeloms.